OmicsChart PREON is a patient-centric cancer data and analytics platform for
translational cancer biologists. The goal of the platform is to enable researchers to gain deeper insights into
patient populations by aggregating data from different sources. PREON contains over 24,000 de-identified cancer
patient records from public and proprietary data providers.
Validate your findings using real-world
data (RWD) and perform biomarker discovery and analytics.
Explore target of interest in 24,000+ patients
Perform complex bioinformatics analytics
Get actionable insights about your target
Search data using our innovative cohort browser by data
type, treatment and create custom cohorts.
OmicsChart PREON contains curated data from
real-world cancer patients from public and propriety data. With more data integrations from public
repositories and commercial providers planned. Simply search and save patient group.
Perform biomarker discovery within and across data
sources.
Characterise both patient group and biomarker/target with OmicsChart PREON.
Explore RNA expression, Tumour Mutational Burden (TMB), Total Tumour mRNA and Homologous Recombinant
Deficiency. Perform correlation between 2 biomarkers, browse top 50 mutated genes and perform survival
analysis. And finally compare biomarkers and their expression across multiple groups in primary, metastatic
and recurrent tumours all in one platform.
Review your analysis results in a secure, interactive
environment.
Whether through custom analytics, biomarker discovery projects, or real-world data validation, all
deliverables from our team are shared via the PREON platform.
Access visual reports, cohort summaries, genomic signatures, and track ongoing service work — all in one
place. Collaborate with our experts directly inside the platform for faster insights and smoother
handoffs.